TearSolutions is a pharmaceutical company that specializes in providing medical solutions for dry eyes.
TearSolutions has raised $517K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
TearSolutions's investors include LaunchCapital, Center for Innovative Technology, Santen Pharmaceutical, Medarva Innovations, UVA Licensing & Ventures Group.
TearSolutions is headquartered in Charlottesville, United States.
TearSolutions is a pharmaceutical company that specializes in providing medical solutions for dry eyes.
TearSolutions is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TearSolutions — Funding & Investors." VCBacked, November 10, 2025, https://www.vcbacked.co/company/tearsolutions. Accessed August 16, 2026.
VCBacked. (2025). TearSolutions — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/tearsolutions
{{cite web |title=TearSolutions — Funding & Investors |url=https://www.vcbacked.co/company/tearsolutions |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated